13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SC Filed 2018-01-04 Event — SEC 0001535610-18-000006 →

SABBY MANAGEMENT, LLC ARCA biopharma, Inc. ORKA

Stake: Shares:

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
20 transactions
0 buys · 13 sales · 5 awards/exercises
Issuer Cluster
7 13D/G filings on this issuer
6 other filings besides this one
Filer Track Record
66 filings by this filer
65 other filings in the data moat
Short Interest · settle 2026-07-15
DTC 6.24
8,833,223 shares short · -3.6% vs prior

Form 4 Insider Transactions · last 365d

DateInsiderRoleTypeSharesPriceValue
2026-07-15 Goncalves Joana officer Option exercise 3,500 $6.84 $24K
2026-07-15 Goncalves Joana officer Option exercise 3,500 $7.80 $27K
2026-07-15 Goncalves Joana officer Sale 400 $84.36 $34K
2026-07-15 Goncalves Joana officer Sale 2,497 $85.86 $214K
2026-07-15 Goncalves Joana officer Sale 3,803 $86.68 $330K
2026-07-15 Goncalves Joana officer Sale 300 $87.25 $26K
2026-07-01 Sandler Laura Lee officer Option exercise 5,000 $7.80 $39K
2026-07-01 Sandler Laura Lee officer Sale 2,237 $93.85 $210K
2026-07-01 Sandler Laura Lee officer Sale 2,263 $94.75 $214K
2026-07-01 Sandler Laura Lee officer Sale 500 $95.47 $48K
2026-07-01 Fairmount Funds Management LLC director, 10%+ owner C 3,553,410
2026-07-01 Fairmount Funds Management LLC director, 10%+ owner Sale 3,553,410 $84.43 $300.01M
2026-07-01 Fairmount Funds Management LLC director, 10%+ owner C 42,641
2026-06-22 Agarwal Arjun officer Sale 888 $80.01 $71K
2026-06-22 Agarwal Arjun officer Sale 699 $82.14 $57K
2026-04-15 Goncalves Joana officer Option exercise 3,500 $6.84 $24K
2026-04-15 Goncalves Joana officer Option exercise 3,500 $7.80 $27K
2026-04-15 Goncalves Joana officer Sale 4,227 $65.73 $278K
2026-04-15 Goncalves Joana officer Sale 2,273 $66.56 $151K
2026-04-15 Goncalves Joana officer Sale 500 $67.38 $34K

Other 13D/G Filings on ARCA biopharma, Inc.

FiledFormFilerStakeShares
2026-07-01 SCHEDULE 13D/A Fairmount Funds Management LLC 19.50% 14,553,895 view →
2025-03-10 SCHEDULE Fairmount Funds Management LLC 19.99% 8,511,824 view →
2022-07-08 SC Funicular Funds, LP view →
2022-04-14 SC Funicular Fund, LP view →
2022-04-04 SC Funicular Fund, LP view →
2018-03-05 SC Growth Equity Opportunities IV, LLC view →

Other Filings by SABBY MANAGEMENT, LLC

FiledFormIssuerStakeShares
2024-01-02 SC Bone Biologics Corp BBLGW view →
2024-01-02 SC Cocrystal Pharma, Inc. COCP view →
2024-01-02 SC AVENUE THERAPEUTICS, INC. ATXI view →
2024-01-02 SC Neptune Wellness Solutions Inc. view →
2024-01-02 SC RedHill Biopharma Ltd. RDHL view →
2024-01-02 SC Toughbuilt Industries, Inc view →
2024-01-02 SC Scinai Immunotherapeutics Ltd. SCNI view →
2024-01-02 SC Onconetix, Inc. ONCO view →
2024-01-02 SC Aditxt, Inc. ADTX view →
2024-01-02 SC Kiromic Biopharma, Inc. view →
2024-01-02 SC Virpax Pharmaceuticals, Inc. view →
2024-01-02 SC Huadi International Group Co., Ltd. HUDI view →
2024-01-02 SC Dogness (International) Corp DOGZ view →
2024-01-02 SC Pulmatrix, Inc. PULM view →
2024-01-02 SC Nisun International Enterprise Development Group Co., Ltd AIOS view →
2018-01-09 SC Axsome Therapeutics, Inc. AXSM view →
2018-01-09 SC CorMedix Inc. CRMD view →
2018-01-09 SC Onconova Therapeutics, Inc. TRAW view →
2018-01-09 SC BIOCEPT INC view →
2018-01-09 SC Trovagene, Inc. CRDF view →
Showing 20 of 65

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →